Transcript of Earnings Conference Call - Q1 FY27

August 10, 2026 Listing Department, Listing Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Dalal Street, Mumbai - 400 051 Mumbai - 400 001 NSE Symbol: ARTEMISMED Scrip Code: 542919 Sub: Transcript of Earnings Conference Call - Q1 FY27 Dear Sir/Ma’am, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed transcript of Earnings Conference Call held on August 4, 2026, to discuss the operational and financial performance of the Company for Q1 FY27. The said transcript is also available on the website of the Company at www.artemishospitals.com/investors. This is for your information and records. Thanking you, Yours faithfully, For Artemis Medicare Services Limited Poonam Makkar Company Secretary and Compliance Officer Encl.: As above “Artemis Medicare Services Limited Q1 FY27 Earnings Conference Call” August 4, 2026 MANAGEMENT: DR. DEVLINA CHAKRAVARTY – MANAGING DIRECTOR MR. SANJIV KOTHARI – CHIEF FINANCIAL OFFICER MR. RUDRA NARAYAN ACHARJEE – HEAD, INVESTOR RELATION, M&A, ORG. GROWTH STRATEGY MODERATOR: MR. HIMANSHU BINANI – ANAND RATHI SHARES AND STOCK BROKING LIMITED Page 1 of 17 Artemis Medicare Services Limited August 4, 2026 Moderator: Ladies and gentlemen, good day and welcome to Artemis Medicare Services Limited Q1 FY27 Earnings Conference Call, hosted by Anand Rathi Shares and Stock Brokers Limited. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Himanshu Binani from Anand Rathi Shares and Stock Brokers Limited. Thank you and over to Mr. Binani. Himanshu Binani: Thank you, Neerav. Good day everyone, and welcome to the Q1 FY27 Earnings Conference Call of Artemis Medicare Services Limited, hosted by Anand Rathi Shares and Stock Brokers. From the management, we have Dr. Devlina Chakravarty, Managing Director; Mr. Sanjiv Kothari, CFO of the company; and Mr. Rudra Narayan Acharjee, Head, Investor Relations. I would like to thank the management for giving us this opportunity to host this call. We'll begin the call with a brief opening remark from management, post which we'll have the session open for Q&A. Without further ado, I would like to hand over the call to Dr. Devlina. Thank you, and over to you, ma'am. Devlina Chakravarty: Thank you, Himanshu. Good morning and thank you for joining us for the earnings call. We hope you all got a chance to go through our Investor Presentation uploaded on the Stock Exchanges. We are pleased to share our financial and operational performance for the quarter ended June 30, 2026. I would like to begin by providing an overview of the healthcare sector and the overall hospital industry. The healthcare sector continues to see a sustained demand for quality, tertiary and quaternary care services supported by increasing awareness, improving access to advanced medical treatments and rising preference for specialized healthcare. At the same time, hospitals continue to focus on expanding capacity, strengthening clinical capabilities and adopting technology to improve patient outcomes and operational efficiency. We believe these trends will continue to support long-term growth for quality healthcare providers. Turning to our performance, Q1 FY27 marked a significant quarter for Artemis as we continue to execute our growth strategy while maintaining our focus on clinical excellence and operational efficiency. Our consolidated revenue from operations for the quarter was at INR 287.32 crores, reflecting a year-on-year growth of 12.7% on a consolidated basis, and standalone year-on-year Gurgaon showed a top-line growth of 15.4%. This performance was supported by sustained demand across our key specialties, particularly cardiology, oncology, neurosciences, and orthopedics, along with continued improvement in case mix and higher contribution from complex procedures. Page 2 of 17 Artemis Medicare Services Limited August 4, 2026 Our EBITDA for the quarter was INR 61.82 crores with an EBITDA margin of 21.5%. The quarter reflects our continued focus on improving operating efficiencies, optimizing resource utilization, and maintaining disciplined cost management across our healthcare network. Our profit after tax for Q1 was reported at INR 31.44 crores, representing a year-on-year growth of 48.3%. The improvement in profitability reflects the strength of our operating model and our continued focus on delivering sustainable and profitable growth. Operationally, our flagship Gurugram hospital continued to perform very well during the quarter, supported by sustained patient volumes across key specialties and continued demand for advanced tertiary and quaternary services. Our occupancy for the quarter was at 65.7%, while average revenue per occupied bed increased to INR 85,690, reflecting continued improvement in case mix and higher contribution from specialized procedures. A key milestone during the quarter was the commencement of operation of Artemis Shanti Hospital, Raipur, our 300-bed multi-specialty tertiary care hospital in Central India. The hospital became operational during the quarter under the Artemis brand, and marks an important step in expanding our presence beyond North India. Equipped with advanced medical infrastructure and comprehensive specialty services, the hospital strengthens our ability to provide quality healthcare across a wider geography while creating an additional growth platform for the company. Although the hospital has very recently commenced operation, we are encouraged by the initial response and expect its contribution to increase as occupancy improves and additional specialties become operational. Our international patient business also continued to perform well during the quarter despite the West Asian war. We continue to witness demand from Middle East, Africa, CIS, and other international markets supported by our strong clinical outcomes and patient experience. Our focus remains on strengthening relationships across these regions while expanding our medical value travel platform through targeted outreach and clinical excellence. On the expansion front, we continue to make steady progress across our growth initiatives. We have received the approval from the shareholders for the proposed QIP, providing us with greater financial flexibility to support our expansion plan. We are in the process of starting our Tower IV at Gurugram facility, subject to getting all the clearances and compliances. This marks another important milestone in our long-term expansion roadmap. The Tower IV in Gurugram would house 200 plus beds within the same campus. Together with our expansion in Raipur and the planned South Delhi facilities, the projects which have already been announced, this would provide a total bed capacity of 2,000 operational beds by 2029-2030. On the clinical front, we continue to strengthen our centers of excellence by expanding specialist capabilities and introducing advanced treatment protocols across key therapeutic areas. Our all- organ transplants program, including our heart and lung transplants, are doing extremely well with great patient outcomes. Page 3 of 17 Artemis Medicare Services Limited August 4, 2026 Technology continues to remain an important part of our operating strategy. We are further expanding our use of AI-enabled patient workflows, digital technologies, and data analytics to improve patient flow, enhance clinical decision-making, and optimize operational efficiency across our hospitals. These initiatives are expected to further improve patient experience while supporting scalabi [Showing first 8,000 characters — download PDF for full document]